Overview
- Samsung signed an acquisition agreement on July 8 to buy U.S. digital-health platform Xealth, with completion expected by year-end pending regulatory approvals.
- The company has kept the financial terms of the transaction confidential.
- Samsung plans to integrate real-time biometric data from Galaxy smartwatches into Xealth’s platform to link home monitoring with hospital care workflows.
- Xealth serves a network of over 500 U.S. hospitals, including Advocate Health and Banner Health, and partners with more than 70 digital-health solution providers.
- The deal follows a 56 percent drop in second-quarter operating profit and underscores Samsung’s push to diversify beyond semiconductors and smartphones.